Cargando…
Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991268/ http://dx.doi.org/10.1186/2051-1426-1-S1-P205 |
| _version_ | 1782312405053734912 |
|---|---|
| author | de Gruijl, Tanja Santegoeds, Saskia van Wetering, Sandra Singh, Satwinder Kaur Hall, Anthony van de Loosdrecht, Arjan A Kruisbeek, Ada |
| author_facet | de Gruijl, Tanja Santegoeds, Saskia van Wetering, Sandra Singh, Satwinder Kaur Hall, Anthony van de Loosdrecht, Arjan A Kruisbeek, Ada |
| author_sort | de Gruijl, Tanja |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3991268 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39912682014-05-05 Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study de Gruijl, Tanja Santegoeds, Saskia van Wetering, Sandra Singh, Satwinder Kaur Hall, Anthony van de Loosdrecht, Arjan A Kruisbeek, Ada J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991268/ http://dx.doi.org/10.1186/2051-1426-1-S1-P205 Text en Copyright © 2013 de Gruijl et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation de Gruijl, Tanja Santegoeds, Saskia van Wetering, Sandra Singh, Satwinder Kaur Hall, Anthony van de Loosdrecht, Arjan A Kruisbeek, Ada Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study |
| title | Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study |
| title_full | Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study |
| title_fullStr | Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study |
| title_full_unstemmed | Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study |
| title_short | Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study |
| title_sort | allogeneic dendritic cell (dc) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of phase i/iia safety and feasibility study |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991268/ http://dx.doi.org/10.1186/2051-1426-1-S1-P205 |
| work_keys_str_mv | AT degruijltanja allogeneicdendriticcelldcvaccinationasanofftheshelftreatmenttopreventordelayrelapseinelderlyacutemyeloidleukemiapatientsresultsofphaseiiiasafetyandfeasibilitystudy AT santegoedssaskia allogeneicdendriticcelldcvaccinationasanofftheshelftreatmenttopreventordelayrelapseinelderlyacutemyeloidleukemiapatientsresultsofphaseiiiasafetyandfeasibilitystudy AT vanweteringsandra allogeneicdendriticcelldcvaccinationasanofftheshelftreatmenttopreventordelayrelapseinelderlyacutemyeloidleukemiapatientsresultsofphaseiiiasafetyandfeasibilitystudy AT singhsatwinderkaur allogeneicdendriticcelldcvaccinationasanofftheshelftreatmenttopreventordelayrelapseinelderlyacutemyeloidleukemiapatientsresultsofphaseiiiasafetyandfeasibilitystudy AT hallanthony allogeneicdendriticcelldcvaccinationasanofftheshelftreatmenttopreventordelayrelapseinelderlyacutemyeloidleukemiapatientsresultsofphaseiiiasafetyandfeasibilitystudy AT vandeloosdrechtarjana allogeneicdendriticcelldcvaccinationasanofftheshelftreatmenttopreventordelayrelapseinelderlyacutemyeloidleukemiapatientsresultsofphaseiiiasafetyandfeasibilitystudy AT kruisbeekada allogeneicdendriticcelldcvaccinationasanofftheshelftreatmenttopreventordelayrelapseinelderlyacutemyeloidleukemiapatientsresultsofphaseiiiasafetyandfeasibilitystudy |